EC Pulmonology and Respiratory Medicine

Background: The COVID-19 pandemic emerged in 2019 as an aggressive respiratory disease. The highly contagious virus spread worldwide and affected millions of people. Due to the novelty of the virus, there was no consensus on effective treatment; consequently, many supportive therapies were commonly used. The primary goal of this study was to determine the use of alternative medicine products (AMP) commonly used during the COVID-19 pandemic and the user’s perception of their benefit.

Methods: For this cross-sectional study, a 20-question survey was created using Google forms. It was distributed via social media from March to May 2022 to subjects at least 18 years of age from different countries. The survey explored participants’ demographics, general health conditions, which alternative medicine products (AMP) were used and why, and COVID-19 infection and immunization history. Data was obtained and analyzed using Google Sheets. Descriptive statistics were used to report results. IRB approval was obtained.

Results: A total of 162 responses were obtained. The great majority of participants were from North America (n = 114; 70.4%), followed by Asia (n = 18; 11.11%) and South America (n = 15; 9.25%). The mean age was 35.55 years (+/- 13.6) and 68.5% were female. Most participants hold a BS (41.4%) or MS (21%) degree. More than half (56.7%) had received 3 doses of the vaccine while only 9% had received none. Most participants use AMPs (n = 148; 91.4%) either always or regularly (51.2%) to either prevent or lessen COVID-19 symptoms 116 (71.6%). The most common AMP used were Vitamin C (56.8%), Vitamin D (54.3%), Zinc (42.6%), and antioxidants (27.7%). Over 70% of subjects (n = 107) reported that the use of AMP let them achieve their desired results.

Conclusion: Despite the limited scientific data supporting the use of alternative medicine products during the COVID-19 pandemic, the results from the survey indicate that they are often used even by fully vaccinated individuals. This use is due in part to the belief that it would help prevent and/or lessen symptoms associated with the virus.

 Keywords: COVID-19 Pandemic; Respiratory Disease; Alternative Medicine Products (AMP)

1. Parizad N., et al. “Effects of guided imagery on anxiety, muscle pain, and vital signs in patients with COVID-19: A randomized controlled trial”. Complementary Therapies in Clinical Practice 43 (2021): 101335.
2. World Health Organization Data. “WHO COVID-19 dashboard” (2024).
3. Xu X., et al. “Efficacy and safety of Reduning injection in the treatment of COVID-19: a randomized, multicenter clinical study”. Annals of Palliative Medicine 5 (2021): 5146-5155.
4. Chen X., et al. “Perioperative care provider’s considerations in managing patients with the COVID-19 infections”. Translational Perioperative and Pain Medicine 2 (2020): 216-224.
5. Natarajan S., et al. “Kabasura Kudineer (KSK), a poly-herbal Siddha medicine, reduced SARS-CoV2 viral load in asymptotic COVID-19 individuals as compared to vitamin C and zinc supplementation: findings from a prospective, exploratory, open-labeled, comparative, randomized control trial, Tamil Nadu, India”. Trials 1 (2021): 623.
6. Charan J., et al. “Use of complementary and alternative medicine (CAM) and home remedies by COVID-19 patients: A telephonic survey”. Indian Journal of Clinical Biochemistry 1 (2020): 108-111.
7. Alschuler L., et al. “Integrative medicine considerations for convalescence from mild-to-moderate COVID-19 disease”. Explore (NY)2 (2022): 140-148.
8. Tangkiatkumjai M., et al. “Potential factors that influence usage of complementary and alternative medicine worldwide: a systematic review”. BMC Complementary Medicine and Therapies 1 (2020): 363.
9. Colunga Biancatelli RML., et al. “Quercetin and vitamin C: An experimental, synergistic therapy for the prevention and treatment of SARS-CoV-2 related disease (COVID-19)”. Frontiers in Immunology 11 (2020): 1451.
10. Luo X., et al. “The add-on effect of Chinese herbal medicine on COVID-19: A systematic review and meta-analysis”. Phytomedicine 85 (2021): 153282.
11. Xiao M., et al. “Efficacy of Huoxiang Zhengq dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial”. Pharmacological Research 161 (2020): 105126.
12. Mahmud R., et al. “Ivermectin in combination with doxycycline for treating COVID-19 symptoms: a randomized trial”. Journal of International Medical Research 5 (2021): 3000605211013550.
13. Dabbous HM., et al. “Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial”. Scientific Reports 1 (2021): 7282.
14. Sekhavati E., et al. “Safety and effectiveness of azithromycin in patients with COVID-19: An open-label randomised trial”. International Journal of Antimicrobial Agents 4 (2020): 106143.
15. Khabour OF and Hassanein SFM. “Use of vitamin/zinc supplements, medicinal plants, and immune boosting drinks during COVID-19 pandemic: A pilot study from Benha City, Egypt”. Heliyon3 (2021): e06538.
16. Zhang S., et al. “Acupressure therapy and Liu Zi Jue Qigong for pulmonary function and quality of life in patients with severe novel coronavirus pneumonia (COVID-19): a study protocol for a randomized controlled trial”. Trials1 (2020): 751.
17. Tavakoli A., et al. “Efficacy of Persian barley water on clinical outcomes of hospitalized moderate-severity COVID-19 patients: a single-blind, add-on therapy, randomized controlled clinical trial”. European Review for Medical and Pharmacological Sciences 3 (2022): 1033-1041.
18. Iddir M., et al. “Strengthening the immune system and reducing inflammation and oxidative stress through diet and nutrition: considerations during the covid-19 crisis”. Nutrients6 (2020): 1562.
19. Ali N. “Role of vitamin D in preventing of COVID-19 infection, progression and severity”. Journal of Infection and Public Health 10 (2020): 1373-1380.
20. Feyaerts AF and Luyten W. “Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19?” Nutrition 79-80 (2020): 110948.
21. Galmés S., et al. “Current state of evidence: influence of nutritional and nutrigenetic factors on immunity in the covid-19 pandemic framework”. Nutrients9 (2020): 2738.
22. Maurya DK and Sharma D. “Evaluation of traditional ayurvedic Kadha for prevention and management of the novel Coronavirus (SARS-CoV-2) using in silico approach”. Journal of Biomolecular Structure and Dynamics 9 (2022): 3949-3964.
23. Brown JD., et al. “Survey-reported medication changes among older adults during the SARS-CoV-2 (COVID-19) pandemic”. Research in Social and Administrative Pharmacy 8 (2021): 1478-1482.
24. Arias A., et al. "Use of a cysteine-rich whey protein isolate as adjuvant therapy in patients with COVID-19 pneumonia: A case series". EC Pulmonology and Respiratory Medicine4 (2022): 30-39.